Dr. Bratslavsky on the Evaluation and Management of Kidney Cancer

Gennedy Bratslavsky, MD
Published: Monday, May 15, 2017



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.

SELECTED
LANGUAGE


Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x